Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1371-1380 of 1,873) with videos related to

Pageof 188
Sort By:
European Journal of Heart Failure|December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HFJames P Curtain, Alice M Jackson, Li Shen, et al.
Circulation. Heart Failure|May 18, 2019
Rationale and Design of the VITALITY-HFpEF TrialJaved Butler, Carolyn S P Lam, Kevin J Anstrom, et al.
Journal of the American College of Cardiology|March 5, 2021
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal FunctionIris E Beldhuis, Peder L Myhre, Michael Bristow, et al.
The New England Journal of Medicine|November 18, 2024
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR CardiomyopathyMarianna Fontana, Scott D Solomon, Jessica Kachadourian, et al.
Journal of the American College of Cardiology|September 25, 2024
Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HFShingo Matsumoto, Li Shen, Alasdair D Henderson, et al.
European Journal of Heart Failure|June 27, 2024
Cardiovascular-kidney-metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HFMats C H Lassen, John W Ostrominski, Brian L Claggett, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 13, 2021
Interference of nuclear mitochondrial DNA segments in mitochondrial DNA testing resembles biparental transmission of mitochondrial DNA in humansRenkui Bai, Hong Cui, Joseph M Devaney, et al.
European Journal of Heart Failure|November 24, 2023
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importanceAdam Ioannou, Muhammad U Rauf, Rishi K Patel, et al.
European Heart Journal|August 26, 2023
Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trialBéla Merkely, Robert Hatala, Jerzy K Wranicz, et al.
Circulation|April 16, 2016
Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) StudiesJonathan W Waks, Colleen M Sitlani, Elsayed Z Soliman, et al.
Pageof 188

Showing results (1371-1380 of 1,873) with videos related to

Sort By:
Pageof 188
European Journal of Heart Failure|December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HFJames P Curtain, Alice M Jackson, Li Shen, et al.
Circulation. Heart Failure|May 18, 2019
Rationale and Design of the VITALITY-HFpEF TrialJaved Butler, Carolyn S P Lam, Kevin J Anstrom, et al.
Journal of the American College of Cardiology|March 5, 2021
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal FunctionIris E Beldhuis, Peder L Myhre, Michael Bristow, et al.
The New England Journal of Medicine|November 18, 2024
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR CardiomyopathyMarianna Fontana, Scott D Solomon, Jessica Kachadourian, et al.
Journal of the American College of Cardiology|September 25, 2024
Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HFShingo Matsumoto, Li Shen, Alasdair D Henderson, et al.
European Journal of Heart Failure|June 27, 2024
Cardiovascular-kidney-metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HFMats C H Lassen, John W Ostrominski, Brian L Claggett, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 13, 2021
Interference of nuclear mitochondrial DNA segments in mitochondrial DNA testing resembles biparental transmission of mitochondrial DNA in humansRenkui Bai, Hong Cui, Joseph M Devaney, et al.
European Journal of Heart Failure|November 24, 2023
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importanceAdam Ioannou, Muhammad U Rauf, Rishi K Patel, et al.
European Heart Journal|August 26, 2023
Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trialBéla Merkely, Robert Hatala, Jerzy K Wranicz, et al.
Circulation|April 16, 2016
Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) StudiesJonathan W Waks, Colleen M Sitlani, Elsayed Z Soliman, et al.
Pageof 188